Carmenta Bioscience
Palo Alto
About Carmenta Bioscience
Carmenta Bioscience is a privately held medical technology company dedicated to improving maternal and fetal health. Spun-out of Stanford University School of Medicine in 2012, Carmenta Bioscience is currently developing a highly accurate, serum-based diagnostic test for preeclampsia.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Last round: Series Unknown (Jan 2014)
- Website: carmentabio.com
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/carmenta-bioscience-2815286 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.